1. Home
  2. CRGX vs FSBC Comparison

CRGX vs FSBC Comparison

Compare CRGX & FSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • FSBC
  • Stock Information
  • Founded
  • CRGX 2021
  • FSBC 2002
  • Country
  • CRGX United States
  • FSBC United States
  • Employees
  • CRGX N/A
  • FSBC N/A
  • Industry
  • CRGX
  • FSBC Banks
  • Sector
  • CRGX
  • FSBC Finance
  • Exchange
  • CRGX Nasdaq
  • FSBC Nasdaq
  • Market Cap
  • CRGX 190.0M
  • FSBC 565.6M
  • IPO Year
  • CRGX 2023
  • FSBC 2021
  • Fundamental
  • Price
  • CRGX $4.46
  • FSBC $30.42
  • Analyst Decision
  • CRGX Hold
  • FSBC Buy
  • Analyst Count
  • CRGX 7
  • FSBC 4
  • Target Price
  • CRGX $4.67
  • FSBC $34.75
  • AVG Volume (30 Days)
  • CRGX 502.9K
  • FSBC 59.3K
  • Earning Date
  • CRGX 08-11-2025
  • FSBC 07-23-2025
  • Dividend Yield
  • CRGX N/A
  • FSBC 2.63%
  • EPS Growth
  • CRGX N/A
  • FSBC N/A
  • EPS
  • CRGX N/A
  • FSBC 2.27
  • Revenue
  • CRGX N/A
  • FSBC $124,973,000.00
  • Revenue This Year
  • CRGX $57.81
  • FSBC $25.86
  • Revenue Next Year
  • CRGX N/A
  • FSBC $15.15
  • P/E Ratio
  • CRGX N/A
  • FSBC $13.40
  • Revenue Growth
  • CRGX N/A
  • FSBC 11.14
  • 52 Week Low
  • CRGX $3.00
  • FSBC $22.22
  • 52 Week High
  • CRGX $25.45
  • FSBC $35.13
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 57.89
  • FSBC 71.55
  • Support Level
  • CRGX $4.09
  • FSBC $28.32
  • Resistance Level
  • CRGX $4.51
  • FSBC $30.04
  • Average True Range (ATR)
  • CRGX 0.18
  • FSBC 0.77
  • MACD
  • CRGX 0.00
  • FSBC 0.33
  • Stochastic Oscillator
  • CRGX 77.18
  • FSBC 99.53

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.

About FSBC Five Star Bancorp

Five Star Bancorp is a bank holding company through its subsidiary it operates in California state-chartered non-member bank. The Company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment; Banking.

Share on Social Networks: